Post-approval studies (Phase 4)Looking for participantsNCT07142343
What this trial is testing
Test the Safety of Pozelimab in Pediatric Participants 1 to 5 Years of Age With a Rare Disease Called CHAPLE (Complement Hyperactivation, Angiopathic Thrombosis, Protein-losing Enteropathy) Disease
Who this might be right for
CHAPLE Disease
Regeneron Pharmaceuticals 5